Literature DB >> 29129516

Is there a potential link between vitamin D and pulmonary morbidities in preterm infants?

Yang Yang1, Yun Feng1, Xu Chen1, Xiao-Nan Mao1, Jing-Han Zhang1, Li Zhao1, You-Yan Zhao1, Rui Cheng2.   

Abstract

BACKGROUND: There hasn't been conclusive proof about the association between vitamin D and pulmonary morbidities of prematurity.
METHODS: 106 preterm infants were retrospectively included into this study. Clinical data and blood samples of all the patients were collected within 24 h of admission.
RESULTS: (1) Respiratory distress syndrome (RDS) patients were mainly concentrated in "≤30 weeks" stage when compared with other two gestational age groups. The only significant decrease of vitamin D concentration between RDS and non-RDS patients reflected in "≤30 weeks" stage (RDS vs. non-RDS: 29.48 ± 13.06 vs. 40.47 ± 20.52 nmol/l). (2) Bronchopulmonary dysplasia (BPD) patients were also concentrated in "≤30 weeks" stage. Vitamin D concentration showed significant difference both in "≤30 weeks" stage and "30-34 weeks" stage (≤30 weeks stage, BPD vs. non-BPD: 33.20 ± 16.51 vs. 39.21 ± 16.65 nmol/l; 30-34 weeks stage, BPD vs. non-BPD: 30.36 ± 15.50 vs. 41.21 ± 20.40 nmol/l). (3) Though vitamin D concentration in mechanical ventilation (MV) group was lower than non-MV group, there're no significant differences. (4) Vitamin D concentration in dead cases was significant lower than survival patients at discharge. (5) It showed a good correlation between vitamin D concentration and serum Ca, serum P, duration of MV and duration of oxygen support in "≤30 weeks" stage.
CONCLUSION: The significant decrease of vitamin D concentration between RDS and non-RDS patients only reflected in "≤30 weeks" stage. And significant decrease of vitamin D concentration in BPD patients was both showed in "≤30 weeks" stage and "30-34 weeks" stage, which is consistent with "duration of oxygen support". However, the overall effect did not show any difference in all preterm infants. It seems that the appropriate concentration of vitamin D is beneficial to lung maturation of human. Certainly, large sample, multi-center randomized controlled trials are necessary.
Copyright © 2017. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  BPD; Preterm infants; RDS; Vitamin D

Mesh:

Substances:

Year:  2017        PMID: 29129516     DOI: 10.1016/j.jcma.2017.07.011

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  3 in total

1.  [Protective effect of vitamin D against hyperoxia-induced bronchopulmonary dysplasia in newborn mice].

Authors:  Hui Chen; Xinxin Chen; Jianfeng Chen; Hong Zhao; Bin Wang; Wei Zheng; Juanjuan Lü; Jiang Du
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-07-30

2.  Association Between Vitamin D Level and Neonatal Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Rina Zang; Yayu Zhang; Hanshuo Zhang; Xueyi Zhang; Yuening Lv; Dan Li
Journal:  Front Pediatr       Date:  2022-01-21       Impact factor: 3.418

3.  Vitamin D and IL-10 Deficiency in Preterm Neonates With Bronchopulmonary Dysplasia.

Authors:  Xiaonan Mao; Jie Qiu; Li Zhao; Junjie Xu; Jiao Yin; Yang Yang; Mingshun Zhang; Rui Cheng
Journal:  Front Pediatr       Date:  2018-09-07       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.